Brain Tumor Program

General Information

The Brain Tumor Program is a multidisciplinary group dedicated to the care of patients with primary brain tumors, brain metastases, recurring brain tumors, and neurological complications of cancer. It is the only multidisciplinary consortium providing comprehensive brain cancer care in southern New England and has gained regional and national recognition.

The physicians of the Brain Tumor Program offer a wide spectrum of advanced strategies for the diagnosis and treatment of brain cancer including microsurgical tumor removal, intraoperative neurophysiological monitoring, specialized genomic profiling, image-guided stereotactic techniques, 3D conformal radiotherapy, stereotactic radiosurgery (gamma knife), and novel, targeted chemotherapies. The program is comprised of the departments of Neurosurgery, Neurology, Medical Oncology, Therapeutic Radiology, Neuropathology, and Neuroradiology. A dedicated patient coordinator facilitates patient appointments and communication, coordinates services, and supports patients and their families.

In addition to novel treatments, the physicians of the Brain Tumor Program conduct clinical trials through Yale Cancer Center for patients with recurring tumors. New trials are also available using immunotherapy treatments.

The expertise of the Brain Tumor Program covers all of the components critical to managing patients with brain tumors: comprehensive evaluation and diagnosis, genomic profiling, leading edge treatment options, thorough follow-up, and psychosocial support. Patients are welcome whether they are newly diagnosed or have already received extensive treatment; patients in need of second surgeries or follow up biopsies are also consulted.

Brain Tumor Program Leadership

Joachim M Baehring, MD headshot

Joachim M Baehring, MD

Clinical Program Leader

Kevin Patrick Becker, MD headshot

Kevin Patrick Becker, MD

Disease Aligned Research Team Leader

People, A-Z